Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
02 May 2019 | Story Xolisa Mnukwa
UFS Debate Society
The UFS Debate Society led by example at the 2019 Jozi Rumble.

After competing in the Jozi Rumble final for six consecutive years, the UFS Debate Society won the competition – Africa’s largest intercollegiate debate open – for the second consecutive year. The tournament took place at the University of the Witwatersrand (Wits) in April 2019.

After seven preliminary rounds, three UFS teams out of a total of 100 competing teams overall were placed in the top 16, earning them a place in the quarterfinals – where they faced each other. A composite team of UFS LLB graduate and LLM student, Lehakoe Masedi, and a partner from Wits beat all teams, qualified for the final themed ‘This house regrets the glorification of opulence in popular culture’, and won the league.

“It was one of the most validating moments of my entire debating career; everybody wants to win the Jozi Rumble, and to have done it and to be the best speaker is truly amazing,” said Lehakoe. The top-ranking speaker at the tournament added that she had been working hard, and that she is glad that her efforts are coming full circle.

The UFS sent six teams overall to the tournament, including two novice teams competing in their first-ever intercollegiate debate tournament. 

“Speaking at the Jozi Rumble debate tournament for the first time was truly an educational experience; it exposed me to the dynamics of varsity-level debating,” said Simphiwe Yana, debater in of the UFS novice teams.

The UFS speaking squad consisted of Lehakoe Masedi, 2018 Abe Bailey Bursary victor and Rhodes scholarship recipient Nkahiseng Ralepeli, Khotso Khokho, Siyanda Rixana, Morena Moabi, Simphiwe Yana, Luvuyo Shoco, Asemahle Noholoza, and Nontobeko Msimangu. Former Chairperson of the UFS Debate Society and Editor-in-Chief of the IRAWA newspaper, Tshiamo Malatji, was also present at the tournament as the Tabulation Director. 

On 11 May 2019, the UFS will travel to the University of Pretoria to defend yet another debate open title at the Pretoria Parlay Intervarsity. 


News Archive

Researchers receive study grant for research into Congo Fever
2015-03-10

UFS researchers will be contributing significantly to the search for a vaccine against the deadly tick-borne disease known as Congo Fever.

Prof Felicity Burt from the Department of Medical Microbiology and Virology was recently awarded a research grant by the National Health Laboratory Service (NHLS) to study candidate vaccines for Crimean-Congo heamorrhagic fever (CCHF) virus and other arboviruses.

Arboviruses are viruses transmitted by mosquitoes, ticks, or other arthropods.

Prof Burt is an internationally-recognised expert on the Crimean-Congo haemorrhagic fever (CCHF). The Crimean-Congo haemorrhagic fever (CCHF) virus is a tick-borne virus that is associated with severe haemorrhagic disease in South Africa and other parts of Africa, Asia, and eastern Europe. Her interests focus on medically significant viruses that are transmitted by ticks and mosquitoes. Her research group is involved in determining the immune responses that are induced by different viral proteins.

Crimean-Congo haemorrhagic fever (CCHF) virus, a tick- borne virus found in Africa, Asia, the Balkans, and eastern Europe, causes severe viral haemorrhagic fever outbreaks.

Although a number of tick species are capable of becoming infected with CCHF virus, ticks of the genus Hyalomma, commonly referred to in SA as the “bont-legged ticks”, are the principal vector. The ticks have distinctive brown and white bands on their legs.

In February 1981, the first case of CCHF was recognised in South Africa (SA). To date, there have been nearly 200 cases of CCHF infection in SA with a 20% fatality rate. The majority of cases occurring in SA were in patients from the Northern Cape and Free State provinces.

“The funding that has been awarded will be used to profile immune responses against CCHF viral proteins, and investigate mechanisms and strategies to enhance these immune responses. We hope that the study will contribute knowledge towards the development of a vaccine against this medically significant virus.”

For more information or enquiries contact news@ufs.ac.za.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept